Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Emergex Vaccines Holdings Ltd.
Headquarters: Abingdon, United Kingdom
Website: http://www.emergexvaccines.com...
Year Founded: 2015
Status: Private
BioCentury | Jun 29, 2023
Management Tracks
Dallas replaces Cunningham as CEO of Rivus
Plus: Stephen Uden named CEO at Rallybio, and updates from Alloy, TScan and more
BioCentury | Feb 25, 2021
Management Tracks
Promotions at Anokion and GlycoMimetics; Read to chair TriNetX and moves at Lava, PYC, Quotient, ImmunoSCAPE and Emergex
Anokion S.A. promoted Deborah Geraghty to president and CEO from COO following John Hohneker’s retirement from the Swiss autoimmune company. The company also promoted Raj Manchanda to chief
BioCentury | Feb 6, 2021
Product Development
Picking vaccine strategies that could hold up to COVID variants
COVID vaccines that induce broad polyclonal responses or potently enlist T cells could upstage single-antigen products when it comes to variants
BioCentury | Nov 19, 2020
Finance
Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more
Elevation raises $65M series B, names Leland CEOElevation Oncology Inc. raised $65 million in a series B round and promoted founder Shawn Leland from CBO to CEO. The venture round was led by
BioCentury | Jan 10, 2020
Financial News
Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas
BioCentury | May 25, 2018
Emerging Company Profile
Universal ambitions
How Emergex aims to create universal vaccines for viral epidemics
Items per page:
1 - 7 of 7